Appleton Partners Inc. MA lessened its holdings in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 3.6% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 63,704 shares of the company's stock after selling 2,412 shares during the quarter. Appleton Partners Inc. MA's holdings in Procter & Gamble were worth $10,149,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors and hedge funds also recently made changes to their positions in the company. Kingstone Capital Partners Texas LLC boosted its stake in Procter & Gamble by 655,209.0% in the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company's stock worth $11,832,680,000 after purchasing an additional 76,017,350 shares during the period. Northern Trust Corp boosted its stake in Procter & Gamble by 0.8% in the 1st quarter. Northern Trust Corp now owns 29,644,000 shares of the company's stock worth $5,051,930,000 after purchasing an additional 248,792 shares during the period. Price T Rowe Associates Inc. MD boosted its stake in Procter & Gamble by 13.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock worth $3,660,737,000 after purchasing an additional 2,466,308 shares during the period. Goldman Sachs Group Inc. boosted its stake in Procter & Gamble by 3.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company's stock worth $2,966,252,000 after purchasing an additional 583,629 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in Procter & Gamble by 6.3% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 17,293,428 shares of the company's stock worth $2,947,146,000 after purchasing an additional 1,018,865 shares during the period. Institutional investors own 65.77% of the company's stock.
Procter & Gamble Stock Performance
Shares of NYSE PG opened at $152.19 on Monday. The stock has a market cap of $356.20 billion, a price-to-earnings ratio of 23.38, a P/E/G ratio of 4.02 and a beta of 0.36. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49. Procter & Gamble Company has a 1-year low of $149.91 and a 1-year high of $180.43. The stock's 50-day moving average is $155.51 and its 200 day moving average is $159.95.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, beating analysts' consensus estimates of $1.42 by $0.06. The company had revenue of $20.89 billion for the quarter, compared to analysts' expectations of $20.79 billion. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.Procter & Gamble's revenue for the quarter was up 1.7% compared to the same quarter last year. During the same period last year, the firm posted $1.40 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, sell-side analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.
Procter & Gamble Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 18th were issued a $1.0568 dividend. The ex-dividend date was Friday, July 18th. This represents a $4.23 annualized dividend and a dividend yield of 2.8%. Procter & Gamble's dividend payout ratio (DPR) is currently 64.82%.
Wall Street Analysts Forecast Growth
PG has been the subject of several analyst reports. BNP Paribas Exane cut their target price on Procter & Gamble from $177.00 to $172.00 and set an "outperform" rating for the company in a research note on Tuesday, September 23rd. JPMorgan Chase & Co. reiterated a "neutral" rating and set a $170.00 price target (down previously from $178.00) on shares of Procter & Gamble in a research report on Friday, July 25th. Wells Fargo & Company dropped their price target on Procter & Gamble from $173.00 to $170.00 and set an "overweight" rating for the company in a research report on Thursday, September 25th. Barclays dropped their price target on Procter & Gamble from $164.00 to $153.00 and set an "equal weight" rating for the company in a research report on Wednesday. Finally, Berenberg Bank lifted their price target on Procter & Gamble from $152.00 to $154.00 and gave the company a "hold" rating in a research report on Wednesday, September 17th. Eleven research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $173.11.
Check Out Our Latest Analysis on PG
Insider Transactions at Procter & Gamble
In other news, COO Shailesh Jejurikar sold 13,039 shares of the firm's stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $2,050,643.53. Following the transaction, the chief operating officer owned 28,036 shares in the company, valued at approximately $4,409,221.72. This trade represents a 31.74% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Gary A. Coombe sold 10,194 shares of the firm's stock in a transaction that occurred on Thursday, August 21st. The stock was sold at an average price of $158.16, for a total transaction of $1,612,283.04. Following the completion of the transaction, the chief executive officer owned 34,978 shares in the company, valued at $5,532,120.48. This represents a 22.57% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 120,181 shares of company stock valued at $18,918,012. 0.20% of the stock is currently owned by insiders.
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report